Rocco Venezia

2021

In 2021, Rocco Venezia earned a total compensation of $856.2K as Interim CFO & Chief Accounting Officer at Intercept Pharmaceuticals.

Compensation breakdown

Bonus$154,000
Non-Equity Incentive Plan$131,648
Option Awards$94,325
Salary$354,554
Stock Awards$101,283
Other$20,423
Total$856,234

Venezia received $354.6K in salary, accounting for 41% of the total pay in 2021.

Venezia also received $154K in bonus, $131.6K in non-equity incentive plan, $94.3K in option awards, $101.3K in stock awards and $20.4K in other compensation.

Rankings

In 2021, Rocco Venezia's compensation ranked 9,278th out of 12,415 executives tracked by ExecPay. In other words, Venezia earned more than 25.3% of executives.

ClassificationRankingPercentile
All
9,278
out of 12,415
25th
Division
Manufacturing
4,114
out of 5,505
25th
Major group
Chemicals And Allied Products
1,814
out of 2,375
24th
Industry group
Drugs
1,611
out of 2,096
23rd
Industry
Pharmaceutical Preparations
1,195
out of 1,546
23rd

Pay ratio

Rocco Venezia's Pay$856,234
Median Employee's Pay$216,748
Pay Ratio

4

to 1

In 2021, the annual total compensation of Rocco Venezia was $856,234.

The annual total compensation of the median employee at Intercept Pharmaceuticals was $216,748.

The ratio of Rocco Venezia's pay to the pay of median employee was therefore 4 to one.

Source: SEC filing on May 2, 2022.

Venezia's colleagues

We found six more compensation records of executives who worked with Rocco Venezia at Intercept Pharmaceuticals in 2021.

2021

Jerome Durso

Intercept Pharmaceuticals

Chief Executive Officer

2021

Jared Freedberg

Intercept Pharmaceuticals

General Counsel

2021

Michelle Berrey

Intercept Pharmaceuticals

Chief Medical Officer

2021

Gail Cawkwell

Intercept Pharmaceuticals

SVP Medical Affairs, Safety & Pharmacovigilance

2021

Andrew Saik

Intercept Pharmaceuticals

Chief Financial Officer

2021

Sandip Kapadia

Intercept Pharmaceuticals

Chief Financial Officer

News

You may also like